Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Biora Therapeutics To Present On The BioJet Systemic Oral Delivery Platform At The Next Gen Peptide Formulation & Delivery Summit 2024

Author: Benzinga Newsdesk | June 11, 2024 08:06am

Biora Therapeutics, Inc. (NASDAQ:BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it will present preclinical data from the BioJet™ Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit, which will take place June 18–20, 2024 in Boston.

 

Details of the presentation are as follows:

BPresentation Title:Empowering Peptide Self Administration with Needle-Free Smart Capsules
Track: Pioneering Devices to Increase the Reach of Peptide APIs
Date & Time:Wednesday, June 19, 2024 from 2:15 to 2:45 PM Eastern time
Presenting Author:Sharat Singh, PhD, Head of Research, Biora Therapeutics, Inc.

Dr. Singh will also participate in a panel discussion on June 19 at 8:45 AM titled "Uncovering Innovations in Peptide Drug Delivery & Formulation for Improved Bioavailability," alongside representatives from Eli Lilly, Merck, and Novo Nordisk.

Posted In: BIOR